Mechanisms of regulation of agonist efficacy at the 5-HT1A receptor by phospholipid-derived signaling components

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 3, 2001, Pages 1025-1035

  Evans, Kenda L J ^a,b   Cropper, Jodie D ^a   Berg, Kelly A ^a   Clarke, William P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ARACHIDONIC ACID; CYCLIC AMP; FORSKOLIN; IONOPHORE; MELITTIN; PHORBOL ESTER; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPID; PROSTAGLANDIN SYNTHASE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CHO CELL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENYLATE CYCLASE; ANIMALS; ARACHIDONIC ACID; CHO CELLS; CHOLERA TOXIN; CRICETINAE; CYCLIC AMP; DINOPROSTONE; ENZYME ACTIVATION; FORSKOLIN; HUMANS; MELITTEN; PHORBOL ESTERS; PHOSPHOLIPASE C; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PROTEIN KINASE C; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0035013845     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. B receptors to the same channels in hippocampus. Science (Wash DC) 234: 1261-1265.
2. Berg KA, Clarke WP, Chen Y, Ebersole BJ, McKay RDG and Maayani S (1994a) 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. Mol Pharmacol 45:826-836.
3. Berg KA, Clarke WP, Sailstad C, Saltzman A and Maayani S (1994b) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol Pharmacol 46:477-484.
4. 1B-like receptor function via arachidonic acid metabolism. Mol Pharmacol 50:1017-1023.
5. Berg KA, Maayani S and Clarke WP (1998a) Interactions between effectors linked to serotonin receptors. Ann N Y Acad Sci 861:111-120.
6. Berg KA, Maayani S, Goldfard J, Scaramellini C, Leff P and Clarke WP (1998b) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94-104.
7. 2C receptor systems. Mol Pharmacol 55:863-872.
8. Blier P and de Montigny C (1999) Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21:S91-S98.
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. 1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies. Brain Res 518:287-291.
11. Colino A and Halliwell JV (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature (Lond) 328:73-77.
12. De Vivo M and Maayani S (1986) Characterization of the 5-hydroxytryptamine 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248-253.
13. Defer N, Best-Belpomme M and Hanoune J (2000) Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol 279:F400-F416.
14. Dickenson JM and Hill SJ (1995) Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells. Br J Pharmacol 116:2889-2896.
15. Ghahremani MH, Cheng P, Lembo PM and Albert PR (1999) Distinct roles for Galphai2, Galphai3, and Gbeta gamma in modulation of forskolin-or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J Biol Chem 274:9238-9245.
16. Giles H, Lansdell SJ, Bolofo ML, Wilson HL and Martin GR (1996) Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding. Br J Pharmacol 117:1119-1126.
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
18. Hanoune J, Pouille Y, Tzavara E, Shen T, Lipskaya L, Miyamoto N, Suzuki Y and Defer N (1997) Adenylyl cyclases: structure, regulation and function in an enzyme superfamily. Mol Cell Endocrinol 128:179-194.
19. 1A receptors. J Pharmacol Exp Ther 268:1098-1106.
20. 1A receptors in P11 cells. J Pharmacol Exp Ther 278:1138-1145.
21. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR and Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
22. Iredale PA and Hill SJ (1993) Increases in intracellular calcium via activation of an endogenous P2-purinoceptor in cultured CHO-K1 cells. Br J Pharmacol 110: 1305-1310.
23. Kung HF, Stevenson DA, Zhuang ZP, Kung MP, Frederick D and Hurt SD (1996) New 5-HT1A receptor antagonist: [3H]p-MPPF. Synapse 23:344-346.
24. 1A receptor by protein kinase C. Mol Pharmacol 48:1024-1029.
25. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
26. Nilsson CL, Hellstrand M, Ekman A and Eriksson E (1998) Direct dopamine D2-receptor-mediated modulation of arachidonic acid release in transfected CHO cells without the concomitant administration of a Ca2+-mobilizing agent. Br J Pharmacol 124:1651-1658.
27. Paterson JM, Smith SM, Harmar AJ and Antoni FA (1995) Control of a novel adenylyl cyclase by calcineurin. Biochem Biophys Res Commun 214:1000-1008.
28. 2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J Neurosci 11:3594-3609.
29. Premont RT, Matsuoka I, Mattei MG, Pouille Y, Defer N and Hanoune J (1996) Identification and characterization of a widely expressed form of adenylyl cyclase. J Biol Chem 271:13900-13907.
30. 1A receptor. J Biol Chem 266:14747-14753.
31. Selbie LA, King NV, Dickenson JM and Hill SJ (1997) Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U) receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors. Biochem J 328:153-158.
32. Serres F, Li Q, Garcia F, Raap DK, Battaglia G, Muma NA and Van de Kar LD (2000) Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo. J Neurosci 20:3095-3103.
33. 2 in cultured cells. Proc Natl Acad Sci USA 76:195-199.
34. Sunahara RK, Dessauer CW and Gilman AG (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461-480.
35. Taussig R, Iniguez-Lluhi JA and Gilman AG (1993) Inhibition of adenylyl cyclase by Gi alpha. Science (Wash DC) 261:218-221.
36. 2+-ATPase. Proc Natl Acad Sci USA 87:2466-2470.
37. Varga EV, Stropova D, Rubenzik M, Wang M, Landsman RS, Roeske WR and Yamamura HI (1998) Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur J Pharmacol 348:R1-R2.
38. Zifa E and Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401-458.